Takenaka K - Search Results

1

Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis.

Shide K, Takenaka K, Kitanaka A, Numata A, Kameda T, Yamauchi T, Inagaki A, Mizuno S, Takami A, Ito S, Hagihara M, Usuki K, Maekawa T, Sunami K, Ueda Y, Tsutsui M, Ando M, Komatsu N, Ozawa K, Kurokawa M, Arai S, Mitani K, Akashi K, Shimoda K. Shide K, et al. Among authors: takenaka k. Ann Hematol. 2024 Jan;103(1):97-103. doi: 10.1007/s00277-023-05528-4. Epub 2023 Nov 10. Ann Hematol. 2024. PMID: 37946031

2

Successful treatment of progressive NK cell lymphoma with allogeneic peripheral stem cell transplantation followed by early cyclosporine tapering and donor leukocyte infusions.

Makita M, Maeda Y, Takenaka K, Shinagawa K, Sunami K, Hiramatsu Y, Fujii N, Ishimaru F, Ikeda K, Niiya K, Yoshino T, Harada M. Makita M, et al. Among authors: takenaka k. Int J Hematol. 2002 Jul;76(1):94-7. doi: 10.1007/BF02982726. Int J Hematol. 2002. PMID: 12138904

3

Tyk2 mutation homologous to V617F Jak2 is not found in essential thrombocythaemia, although it induces constitutive signaling and growth factor independence.

Shide K, Shimoda K, Kamezaki K, Kakumitsu H, Kumano T, Numata A, Ishikawa F, Takenaka K, Yamamoto K, Matsuda T, Harada M. Shide K, et al. Among authors: takenaka k. Leuk Res. 2007 Aug;31(8):1077-84. doi: 10.1016/j.leukres.2006.08.018. Epub 2006 Sep 29. Leuk Res. 2007. PMID: 17011030

4

[Acute lymphoblastic leukemia presenting with calcineurin-inhibitor induced pain syndrome after a second allogeneic bone marrow transplantation].

Takashima S, Numata A, Miyamoto T, Shirakawa T, Kinoshita R, Kato K, Takenaka K, Harada N, Nagafuji K, Taniguchi S, Harada M. Takashima S, et al. Among authors: takenaka k. Rinsho Ketsueki. 2006 Oct;47(10):1372-6. Rinsho Ketsueki. 2006. PMID: 17094576 Japanese.

5

Primary hepatic lymphoma 1 year after resection of hepatocellular carcinoma.

Nonami A, Takenaka K, Harada N, Kono K, Kamezaki K, Numata A, Karube K, Miyamoto T, Nagafuji K, Ohshima K, Harada M. Nonami A, et al. Among authors: takenaka k. J Clin Oncol. 2006 Dec 20;24(36):5784-6. doi: 10.1200/JCO.2006.08.5654. J Clin Oncol. 2006. PMID: 17179113 No abstract available.

6

Distinctive expression of myelomonocytic markers and down-regulation of CD34 in acute myelogenous leukaemia with FLT3 tandem duplication and nucleophosmin mutation.

Mori Y, Yoshimoto G, Kumano T, Miyamoto T, Iino T, Takenaka K, Iwasaki H, Harada N, Kinukawa N, Nagafuji K, Teshima T, Shimoda K, Akashi K, Harada M. Mori Y, et al. Among authors: takenaka k. Eur J Haematol. 2007 Jul;79(1):17-24. doi: 10.1111/j.1600-0609.2007.00866.x. Eur J Haematol. 2007. PMID: 17598835

7

Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival.

Kikushige Y, Yoshimoto G, Miyamoto T, Iino T, Mori Y, Iwasaki H, Niiro H, Takenaka K, Nagafuji K, Harada M, Ishikawa F, Akashi K. Kikushige Y, et al. Among authors: takenaka k. J Immunol. 2008 Jun 1;180(11):7358-67. doi: 10.4049/jimmunol.180.11.7358. J Immunol. 2008. PMID: 18490735

8

Successful treatment of parainfluenza virus 3 pneumonia with oral ribavirin and methylprednisolone in a bone marrow transplant recipient.

Shima T, Yoshimoto G, Nonami A, Yoshida S, Kamezaki K, Iwasaki H, Takenaka K, Miyamoto T, Harada N, Teshima T, Akashi K, Nagafuji K. Shima T, et al. Among authors: takenaka k. Int J Hematol. 2008 Oct;88(3):336-340. doi: 10.1007/s12185-008-0148-6. Epub 2008 Aug 19. Int J Hematol. 2008. PMID: 18712461

9

Additional acquisition of t(1;21)(p32;q22) in a patient relapsing with acute myelogenous leukemia with NUP98-HOXA9.

Aoki T, Miyamoto T, Yoshida S, Yamamoto A, Yamauchi T, Yoshimoto G, Mori Y, Kamezaki K, Iwasaki H, Takenaka K, Harada N, Nagafuji K, Teshima T, Akashi K. Aoki T, et al. Among authors: takenaka k. Int J Hematol. 2008 Dec;88(5):571-574. doi: 10.1007/s12185-008-0198-9. Epub 2008 Nov 13. Int J Hematol. 2008. PMID: 19005624

10

Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients.

Takenaka K, Eto T, Nagafuji K, Kamezaki K, Matsuo Y, Yoshimoto G, Harada N, Yoshida M, Henzan H, Takase K, Miyamoto T, Akashi K, Harada M, Teshima T; for Fukuoka Blood and Marrow Transplant Group (FBMTG). Takenaka K, et al. Int J Hematol. 2009 Mar;89(2):231-237. doi: 10.1007/s12185-008-0249-2. Epub 2009 Jan 17. Int J Hematol. 2009. PMID: 19148587 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,143 results

Search Page

Filters